Edinburgh Biosciences aim to revolutionize
cataract diagnosis and treatment

Edinburgh Biosciences Ltd (EBS) was formed in 2013 as a spin-out from Edinburgh Instruments (EI) by Prof S. Desmond Smith, OBE, FRS, FRSE, F. InstP who originally founded EI in 1971.

Recent research and development work at EBS has focused on developing new technologies to improve cataract diagnosis and provide an alternative to surgery by non-invasive treatment. Following the successful completion of EU ICT Funded Project CATACURE with 6 European partners, EBS are looking to further the technology development and aim to progress through human clinical trials towards a global solution for cataract.